María Eugenia Pachón-Ibáñez

Author

Also Known As

M E Pachón-Ibáñez, M Eugenia Pachón-Ibáñez, M. E. Pachon-Ibanez, M. E. Pachón-Ibañez, M. E. Pachón Ibáñez, M. E. Pachón-Ibañez, M. E. Pachón-Ibáñez, M. Eugenia Pachón-Ibañez, M. Eugenia Pachón-Ibáñez, M.E. Ibáñez

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Universidad de Sevilla Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío Hospital Universitario Virgen Macarena Universitat de Barcelona

About

María Eugenia Pachón-Ibáñez is an author at Universidad de Sevilla specializing in medicine, antimicrobial resistance, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	816
2	Health Sciences	14	14	578
3	Engineering	1	1	17
4	Natural Sciences	1	1	126
5	Allergy	1	1	25

María Eugenia Pachón-Ibáñez

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Activity of Tigecycline (GAR-936) against <i>Acinetobacter baumannii</i> Strains, Including Those Resistant to Imipenem María Eugenia Pachón-Ibáñez, Jiménez-Mejías Me, C. Pichardo, Antimicrobial Agents and Chemotherapy Vitro Bacteriostatic ActivityAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2004	170
Modern venomics—Current insights, novel methods, and future perspectives in biological and applied animal venom research Björn M. von Reumont, Gregor Anderluh, Agostinho Antunes, GigaScience Novel MethodsFuture PerspectivesToxinologyBiomolecular ToolMolecular Biology	2022	126
Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of <i>Acinetobacter baumannii</i> Luis Alberto Rodríguez Arroyo, A. García-Curiel, María Eugenia Pachón-Ibáñez, Journal of Clinical Microbiology	2005	120
Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant <i>Acinetobacter baumannii</i> María Eugenia Pachón-Ibáñez, Fernando Docobo-Pérez, Rafael López-Rojas, Antimicrobial Agents and Chemotherapy	2010	115
Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of <i>Acinetobacter baumannii</i> : Molecular Basis for the Differential Mechanisms of Action José María Saugar, María Jesús Rodríguez-Hernández, Beatriz G. de la Torre, Antimicrobial Agents and Chemotherapy Microbial PathogensAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug Resistance	2006	89
Combating virulence of Gram-negative bacilli by OmpA inhibition Xavier Vila‐Farrés, Raquel Parra-Millán, Viviana Sánchez-Encinales, Scientific Reports	2017	82
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae Rafael Ayerbe-Algaba, María Luisa Gil-Marqués, Jiménez-Mejías Me, Frontiers in Cellular and Infection Microbiology	2018	72
Pangenome of Acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation Eugenio L. Mangas, Alejandro Rubio, Rocío Álvarez‐Marín, Microbial Genomics	2019	65
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia Máximo Bernabéu-Wittel, C. Pichardo, A. García-Curiel, Clinical Microbiology and Infection Antimicrobial SusceptibilityHealth SciencesAntibioticsPharmacokinetic/pharmacodynamic AssessmentPharmacology	2005	60
Overproduction of outer membrane protein A (OmpA) by <i>Acinetobacter baumannii</i> is a risk factor for nosocomial pneumonia, bacteremia and mortality increase. Viviana Sánchez-Encinales, Rocío Álvarez‐Marín, María Eugenia Pachón-Ibáñez, The Journal of Infectious Diseases	2017	59

Page 1